Info

Isolagen, Inc.(Isolagen) is an aesthetic and therapeutic development stage company focused on developing skin and tissue rejuvenation products. The Company's clinical development product candidates are designed to improve the appearance of skin injured by the effects of aging, sun exposure, acne and burn scars with a patient’s own, or autologous, fibroblast cells produced by its Isolagen Process. Isolagen's clinical development programs encompass both aesthetic and therapeutic indications. The Isolagen Therapy is for the treatment of nasolabial folds/wrinkles and is in Phase III clinical development. The Company also has an ongoing Phase II/III study for the treatment of acne scars and ongoing Phase II studies related to full face rejuvenation, restrictive burns scars and periodontal disease. Isolagen also develops and markets a skin care product line through its Agera Laboratories, Inc. subsidiary, in which it owns a 57% interest.(Source: 10-K)